PGNY.NASDAQProgyny, INC

Form 4: Progyny CFO Mark Livingston Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Progyny's CFO, Mark Livingston, reports acquisition and disposal of company stock and stock options, including transactions related to vesting and tax obligations.

Summary

  • On March 4, 2024, Mark Livingston, CFO of Progyny, Inc., acquired 15,000 shares of common stock related to restricted stock units (RSUs) at a price of $0.
  • On April 1, 2024, Livingston exercised stock options to acquire 20,627 shares of common stock at $3.95 per share.
  • Also on April 1, 2024, 11,591 shares were withheld for payment of withholding taxes related to the stock option exercise at a price of $37.643.
  • Livingston sold 2,129 shares on April 1, 2024, at $37.60 and 9,036 shares at $37.6194, both sales were executed under a pre-arranged Rule 10b5-1 trading plan.
  • Following these transactions, Livingston directly owns 50,119 shares of Progyny common stock.
  • Livingston also acquired 45,000 stock options on March 4, 2024, at an exercise price of $35.48.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The transactions are routine and expected, with no indication of significant positive or negative developments. The sales are pre-planned and don't necessarily reflect a lack of confidence.

Positives

  • The acquisition of shares through RSUs and stock option exercises demonstrates Livingston's investment in the company's future.

Negatives

  • The sale of shares, even under a 10b5-1 plan, could be interpreted negatively by some investors, although it is a pre-planned and disclosed activity.

Risks

  • Executive stock sales can sometimes create uncertainty in the market, even when conducted under pre-arranged plans.

Future Outlook

The vesting schedule for the RSUs and stock options extends through March 4, 2028, contingent on continued service.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are closely monitored by investors for insights into management's perspective on the company's value and future prospects.

Comparison to Industry Standards

  • Executive compensation packages often include stock options and RSUs to align management's interests with those of shareholders.
  • Rule 10b5-1 trading plans are a standard practice for executives to manage their stock sales in compliance with insider trading regulations.
  • The vesting schedules and exercise prices are typical for equity-based compensation in the tech and healthcare industries.

Stakeholder Impact

  • The transactions have a limited direct impact on stakeholders, as they are part of standard executive compensation practices.
  • Shareholders may monitor these transactions for insights into management's views on the company's stock value.

Key Dates

DateDescription
03/04/2024Acquisition of 15,000 shares of common stock via RSUs and grant of 45,000 stock options.
04/01/2024Exercise of stock options for 20,627 shares, withholding of 11,591 shares for taxes, and sales of 2,129 and 9,036 shares under a 10b5-1 plan.
04/03/2024Date of Form 4 signature.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.